These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
795 related articles for article (PubMed ID: 28459449)
1. In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Roper J; Tammela T; Cetinbas NM; Akkad A; Roghanian A; Rickelt S; Almeqdadi M; Wu K; Oberli MA; Sánchez-Rivera FJ; Park YK; Liang X; Eng G; Taylor MS; Azimi R; Kedrin D; Neupane R; Beyaz S; Sicinska ET; Suarez Y; Yoo J; Chen L; Zukerberg L; Katajisto P; Deshpande V; Bass AJ; Tsichlis PN; Lees J; Langer R; Hynes RO; Chen J; Bhutkar A; Jacks T; Yilmaz ÖH Nat Biotechnol; 2017 Jun; 35(6):569-576. PubMed ID: 28459449 [TBL] [Abstract][Full Text] [Related]
2. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer. O'Rourke KP; Loizou E; Livshits G; Schatoff EM; Baslan T; Manchado E; Simon J; Romesser PB; Leach B; Han T; Pauli C; Beltran H; Rubin MA; Dow LE; Lowe SW Nat Biotechnol; 2017 Jun; 35(6):577-582. PubMed ID: 28459450 [TBL] [Abstract][Full Text] [Related]
3. Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation. Roper J; Tammela T; Akkad A; Almeqdadi M; Santos SB; Jacks T; Yilmaz ÖH Nat Protoc; 2018 Feb; 13(2):217-234. PubMed ID: 29300388 [TBL] [Abstract][Full Text] [Related]
4. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance. Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111 [TBL] [Abstract][Full Text] [Related]
5. An In Vivo Metastasis Model Using Genotype-Defined Tumor Organoids. Morita A; Nakayama M; Oshima H; Oshima M Methods Mol Biol; 2024; 2828():57-68. PubMed ID: 39147970 [TBL] [Abstract][Full Text] [Related]
6. Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis. Tang J; Feng Y; Kuick R; Green M; Green M; Sakamoto N; Kurosu Y; Lin J; Cho KR; Fearon ER Lab Invest; 2019 Oct; 99(10):1454-1469. PubMed ID: 31148594 [TBL] [Abstract][Full Text] [Related]
7. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
8. [Mouse models for human colorectal cancer with liver metastasis]. Huang XD; Zheng YB; Yang YJ; Yang C; Li HL; Cheng HR Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2701-2705. PubMed ID: 31505723 [No Abstract] [Full Text] [Related]
9. Rapid interrogation of cancer cell of origin through CRISPR editing. Feng W; Cao Z; Lim PX; Zhao H; Luo H; Mao N; Lee YS; Rivera AA; Choi D; Wu C; Han T; Romero R; de Stanchina E; Carver BS; Wang Q; Jasin M; Sawyers CL Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34353917 [TBL] [Abstract][Full Text] [Related]
10. Combined Mutation of Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223 [TBL] [Abstract][Full Text] [Related]
11. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer. Boos SL; Loevenich LP; Vosberg S; Engleitner T; Öllinger R; Kumbrink J; Rokavec M; Michl M; Greif PA; Jung A; Hermeking H; Neumann J; Kirchner T; Rad R; Jung P Cell Mol Gastroenterol Hepatol; 2022; 13(2):517-540. PubMed ID: 34700030 [TBL] [Abstract][Full Text] [Related]
12. Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy. Wan T; Chen Y; Pan Q; Xu X; Kang Y; Gao X; Huang F; Wu C; Ping Y J Control Release; 2020 Jun; 322():236-247. PubMed ID: 32169537 [TBL] [Abstract][Full Text] [Related]
13. P53 ICE CRIM mouse: a tool to generate mutant allelic series in somatic cells and germ lines for cancer studies. Fan HH; Yu IS; Lin YH; Wang SY; Liaw YH; Chen PL; Yang TL; Lin SW; Chen YT FASEB J; 2019 Apr; 33(4):5571-5584. PubMed ID: 30640520 [TBL] [Abstract][Full Text] [Related]
14. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids. Michels BE; Mosa MH; Streibl BI; Zhan T; Menche C; Abou-El-Ardat K; Darvishi T; Członka E; Wagner S; Winter J; Medyouf H; Boutros M; Farin HF Cell Stem Cell; 2020 May; 26(5):782-792.e7. PubMed ID: 32348727 [TBL] [Abstract][Full Text] [Related]
15. A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression. Fumagalli A; Suijkerbuijk SJE; Begthel H; Beerling E; Oost KC; Snippert HJ; van Rheenen J; Drost J Nat Protoc; 2018 Feb; 13(2):235-247. PubMed ID: 29300390 [TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes. Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537 [TBL] [Abstract][Full Text] [Related]
17. Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Sánchez-Rivera FJ; Papagiannakopoulos T; Romero R; Tammela T; Bauer MR; Bhutkar A; Joshi NS; Subbaraj L; Bronson RT; Xue W; Jacks T Nature; 2014 Dec; 516(7531):428-31. PubMed ID: 25337879 [TBL] [Abstract][Full Text] [Related]
18. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling. Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510 [TBL] [Abstract][Full Text] [Related]
19. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875 [TBL] [Abstract][Full Text] [Related]
20. Efficient genetic editing of human intestinal organoids using ribonucleoprotein-based CRISPR. Skoufou-Papoutsaki N; Adler S; D'Santos P; Mannion L; Mehmed S; Kemp R; Smith A; Perrone F; Nayak K; Russell A; Zilbauer M; Winton DJ Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37772705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]